Osteoclasts are essential for TNF-α-mediated joint destruction.
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
The detailed cellular and molecular mechanisms leading to joint destruction in rheumatoid arthritis, a disease driven by proinflammatory cytokines, are still unknown. To address the question of whether osteoclasts play a pivotal role in this process, transgenic mice that express human TNF (hTNFtg) and that develop a severe and destructive arthritis were crossed with osteopetrotic, c-fos–deficient mice (c-fos–/–) completely lacking osteoclasts. The resulting mutant mice (c-fos–/–hTNFtg) developed a TNF-dependent arthritis in the absence of osteoclasts. All clinical features of arthritis, such as paw swelling and reduction of grip strength, progressed equally in both groups. Histological evaluation of joint sections revealed no difference in the extent of synovial inflammation, its cellular composition (except for the lack of osteoclasts), and the expression of matrix metalloprotein-ase-3 (MMP-3) and MMP-13. In addition, cartilage damage, proteoglycan loss, and MMP-3, -9, and -13 expression in chondrocytes were similar in hTNFtg and c-fos–/–hTNFtg mice. However, despite the presence of severe inflammatory changes, c-fos–/–hTNFtg mice were fully protected against bone destruction. These data reveal that TNF-dependent bone erosion is mediated by osteoclasts and that the absence of osteoclasts alters TNF-mediated arthritis from a destructive to a nondestructive arthritis. Therefore, in addition to the use of anti-inflammatory therapies, osteoclast inhibition could be beneficial for the treatment of rheumatoid arthritis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Certainly the high circulating levels of TNF-␣ and IL-1 that are common in RA have the potential to promote osteoclastogenesis throughout the skeleton (223,237,(423)(424)(425).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [425]
Citations
Cites
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Lipsky, P. E., van der Heijde, D. M. F. M., St. Clair, E. W., Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Weisman, M., Emery, P., Feldmann, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432202 · Cited by 2,996
Self-citationROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,336
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
Self-citation
Research works printed but not linked: 4
- Okada, 1995, Lab Invest, 72, 311
- Pap, 1999, J Rheumatol, 26, 166
- Gravallese, 1998, Am J Pathol, 152, 943
- Douni, 1995, J Inflamm, 47, 27
Cited by
Items 201–300 of 478
Kawai, V. K., Grijalva, C. G., Arbogast, P. G., Curtis, J. R., Solomon, D. H., Delzell, E., Chen, L., Ouellet‐Hellstrom, R., Herrinton, L. J., Liu, L., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21937 · Cited by 49
Tomita, T., Kakiuchi, Y., & Tsao, P. S. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1856 · Cited by 48
Wäldele, S., Wunrau, C., Beckmann, D., Korb‐Pap, A., Wehmeyer, C., Pap, T., & Dankbar, B. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0524-6 · Cited by 48
Hayer, S., Bauer, G., Willburger, M., Sinn, K., Alasti, F., Plasenzotti, R., Shvets, T., Niederreiter, B., Aschauer, C., Steiner, G. E., et al. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.025460 · Cited by 56
Self-citationPeng, M., Wang, Y., Qiang, L., Xu, Y., Li, C., Li, T., Zhou, X., Xiao, M., & Wang, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01417 · Cited by 50
Immune-bone interplay in the structural damage in rheumatoid arthritis
Komatsu, N., & Takayanagi, H. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13188 · Cited by 50
Park, S. Y., Lee, S. W., Baek, S., Lee, C., Lee, W., Rhim, B., Hong, K., & Kim, C. D. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12021 · Cited by 47
Stat1-mediated cytoplasmic attenuation in osteoimmunology
Takayanagi, H., Kim, S., Koga, T., & Taniguchi, T. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20316 · Cited by 47
Mechanisms modulating inflammatory osteolysis: A review with insights into therapeutic targets
Shi, W., & Siegal, G. P. (2008) · Pathology - Research and Practice · doi:10.1016/j.prp.2008.07.002 · Cited by 50
Li, Y., Chen, C., Trinh‐Minh, T., Zhu, H., Matei, A., Györfi, A., Kuwert, F., Hubel, P., Ding, X., Manh, C. T., et al. (2022) · Bone Research · doi:10.1038/s41413-022-00218-9 · Cited by 48
Self-citationTherapeutic targeting of osteoclast function and pathways
Broadhead, M. L., Clark, J. C. M., Dass, C. R., Choong, P., & Myers, D. E. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.546351 · Cited by 51
IL-3 Inhibits TNF-α-Induced Bone Resorption and Prevents Inflammatory Arthritis
Yogesha, S. D., Khapli, S. M., Srivastava, R. K., Mangashetti, L. S., Pote, S. T., Mishra, G. C., & Wani, M. R. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.361 · Cited by 48
Shen, W.-R., Kimura, K., Ishida, M., Sugisawa, H., Kishikawa, A., Shima, K., Ogawa, S., Qi, J., & Kitaura, H. (2018) · Journal of Immunology Research · doi:10.1155/2018/5783639 · Cited by 45
Hou, K., Lin, S., Chao, L., Lai, E. H., Chang, C., Shun, C., Lu, W., Wang, J., Hsiao, M., Hong, C., et al. (2016) · BioFactors · doi:10.1002/biof.1320 · Cited by 49
Bisphosphonates: Environmental protection for the joint?
Goldring, S. R., & Gravallese, E. M. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20383 · Cited by 46
Toyama, S., Tamura, N., Haruta, K., Karakida, T., Mori, S., Watanabe, T., Yamori, T., & Takasaki, Y. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3019 · Cited by 47
Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis
Confavreux, C. B., & Chapurlat, R. D. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1462-4 · Cited by 45
Kim, H.-K., Han, H., Lee, K.-S., Lee, D., Lee, J.-W., Jeon, H., Cho, S.-Y., Roh, H.-J., Kim, Y.-C., & Seok, H. (2016) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2166 · Cited by 47
20 years of experience with tumour necrosis factor inhibitors: what have we learned?
Caporali, R. F., Crepaldi, G., Codullo, V., Benaglio, F., Monti, S. M., Todoerti, M., & Montecucco, C. (2018) · Rheumatology · doi:10.1093/rheumatology/key059 · Cited by 44
Excavatolide B Attenuates Rheumatoid Arthritis through the Inhibition of Osteoclastogenesis
Lin, Y., Jean, Y., Lee, H.-P., Lin, S., Pan, C., Chen, W.-F., Wu, S.-F., Su, J., Tsui, K., Sheu, J., et al. (2017) · Marine Drugs · doi:10.3390/md15010009 · Cited by 45
Geboes, L., Klerck, B. D., Balen, M. V., Kelchtermans, H., Mitera, T., Boon, L., Wolf‐Peeters, C. D., & Matthys, P. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22791 · Cited by 48
Suematsu, A., Tajiri, Y., Nakashima, T., Taka, J., Ochi, S., Oda, H., Nakamura, K., Tanaka, S., & Takayanagi, H. (2007) · Modern Rheumatology · doi:10.1007/s10165-006-0531-1 · Cited by 45
Targeted etanercept for treatment-refractory pain due to bone metastasis: Two case reports
Tobinick, E. L. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80219-9 · Cited by 44
Using a Novel MicroRNA Delivery System to Inhibit Osteoclastogenesis
Yao, Y., Jia, T., Pan, Y., Gou, H., Li, Y., Sun, Y., Zhang, R., Zhang, K., Lin, G., Xie, J., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16048337 · Cited by 43
Interleukin-9 Facilitates Osteoclastogenesis in Rheumatoid Arthritis
Kar, S., Gupta, R., Malhotra, R., Sharma, V., Farooque, K., Kumar, V. L., Chakraborty, S., & Mitra, D. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910397 · Cited by 46
Bilasy, S. E., Essawy, S. S., Mandour, M. F., Ali, E., & Zaitone, S. A. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.08.009 · Cited by 42
Hayer, S., Tohidast-Akrad, M., Haralambous, S., Jahn‐Schmid, B., Skriner, K., Trembleau, S., Dumortier, H., Piñol-Roma, S., Redlich, K., Schett, G. A., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8327 · Cited by 41
Self-citationIL‐37b alleviates inflammation in the temporomandibular joint cartilage via IL‐1R8 pathway
Luo, P., Feng, C., Jiang, C. Y., Ren, X., Gou, L., Ji, P., & Xu, J. (2019) · Cell Proliferation · doi:10.1111/cpr.12692 · Cited by 43
Zhou, C., You, Y., Shen, W., Zhu, Y. Z., Peng, J., Feng, H., Wang, Y., Li, D., Shao, W., Li, C.-X., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-207134 · Cited by 42
Zhang, Z.-Q., Cao, W., Shivappa, N., Hébert, J. R., Li, B., He, J., Tang, X., Liang, Y., & Chen, Y. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.02.011 · Cited by 42
Pfeil, A., Haugeberg, G., Hansch, A., Renz, D. M., Lehmann, G., Malich, A., Wolf, G., & Böttcher, J. (2011) · Arthritis Care & Research · doi:10.1002/acr.20423 · Cited by 42
de Castro, L. F., Lozano, D., Dapía, S., Portal‐Núñez, S., Caeiro, J. R., Gómez‐Barrena, E., & Esbrit, P. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0355 · Cited by 40
Peyruchaud, O., Saier, L., & Leblanc, R. (2019) · Cancers · doi:10.3390/cancers12010105 · Cited by 38
Osteoimmunology: A View from the Bone
David, J. (2007) · Advances in immunology · doi:10.1016/s0065-2776(07)95005-1 · Cited by 45
Self-citationActivity study of a hydroxynaphthoquinone fraction from Arnebia euchroma in experimental arthritis
Fan, H., Yang, M., Che, X., Zhang, Z., Xu, H. F., Liu, K., & Meng, Q. (2012) · Fitoterapia · doi:10.1016/j.fitote.2012.06.011 · Cited by 37
Soluble RANKL in Crevicular Fluid of Dental Implants: A Pilot Study
Monov, G., Strbac, G. D., Baron, M., Kandler, B., Watzek, G., & Gruber, R. (2006) · Clinical Implant Dentistry and Related Research · doi:10.1111/j.1708-8208.2006.00012.x · Cited by 37
TNFα inhibits the development of osteoclasts through osteoblast-derived GM-CSF
Atanga, E., Dolder, S., Dauwalder, T., Wetterwald, A., & Hofstetter, W. (2011) · Bone · doi:10.1016/j.bone.2011.08.003 · Cited by 37
DPP-4 inhibitor impedes lipopolysaccharide-induced osteoclast formation and bone resorption in vivo
Ishida, M., Shen, W.-R., Kimura, K., Kishikawa, A., Shima, K., Ogawa, S., Qi, J., Ohori, F., Noguchi, T., Marahleh, A., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.052 · Cited by 36
Queiroz‐Junior, C. M., Bessoni, R. L. C., Costa, V. V., Souza, D. G., Teixeira, M. M., & Silva, T. A. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.07.022 · Cited by 37
IL-37 inhibits lipopolysaccharide-induced osteoclast formation and bone resorption in vivo
Saeed, J., Kitaura, H., Kimura, K., Ishida, M., Sugisawa, H., Ochi, Y., Kishikawa, A., & Takano‐Yamamoto, T. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.04.004 · Cited by 39
Allard‐Chamard, H., Carrier, N., Dufort, P., Durand, M., de Brum-Fernandes, A. J., Boire, G., Komarova, S. V., Dixon, S. J., Harrison, R. E., Manolson, M. F., et al. (2020) · Bone Reports · doi:10.1016/j.bonr.2020.100282 · Cited by 36
Chen, X., Zhang, H., Wu, J., Wang, N., Lo, H. H., Ip, C. K., Li, Y., Hsiao, W. L. W., Sin, W. M., Xia, C., et al. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.08.015 · Cited by 37
Schurigt, U., Hummel, K. M., Petrow, P. K., Gajda, M. R., Stöckigt, R., Middel, P., Zwerina, J., Janik, T., Bernhardt, R., Schüler, S., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23224 · Cited by 36
Self-citationKato, G., Shimizu, Y., Arai, Y., Suzuki, N., Sugamori, Y., Maeda, M., Takahashi, M., Tamura, Y., Wakabayashi, N., Murali, R., et al. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0753-8 · Cited by 36
JNK1 is not essential for TNF-mediated joint disease
Köller, M. D., Hayer, S., Redlich, K., Ricci, R., David, J.-P., Steiner, G. E., Smolen, J. S., Wagner, E. F., & Schett, G. A. (2004) · Arthritis Research & Therapy · doi:10.1186/ar1473 · Cited by 36
Self-citationLiu, Q., Zhao, J., Tan, R. X., Zhou, H., Lin, Z., Zheng, M., Romas, E., Xu, J., & Sims, N. A. (2014) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2014.938113 · Cited by 36
Anti‐RANKL therapy for inflammatory bone disorders: Mechanisms and potential clinical applications
Anandarajah, A., & Schwarz, E. M. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20674 · Cited by 37
Kim, J. Y., Lee, E. Y., Lee, E. B., Lee, Y. J., Yoo, H. J., Choi, J. Y., & Song, Y. W. (2012) · Arthritis Research & Therapy · doi:10.1186/ar4018 · Cited by 35
Zwerina, J., Tuerk, B., Redlich, K., Smolen, J. S., & Schett, G. A. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1872 · Cited by 35
Self-citationInflammatory signaling induced bone loss
Goldring, S. R. (2015) · Bone · doi:10.1016/j.bone.2015.05.024 · Cited by 34
Substituted Isoxazoles as Potent Inhibitors of p38 MAP Kinase
Laufer, S., Margutti, S., & Fritz, M. D. (2005) · ChemMedChem · doi:10.1002/cmdc.200500025 · Cited by 36
Effects of C-reactive protein on bone cells
Cho, I.-J., Choi, K. H., Oh, C. H., Hwang, Y., Jeong, I., Ahn, K. J., & Chung, H.-Y. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.12.021 · Cited by 35
Low-Dose Radiotherapy Has No Harmful Effects on Key Cells of Healthy Non-Inflamed Joints
Deloch, L., Rückert, M., Fietkau, R., Frey, B., & Gaipl, U. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103197 · Cited by 39
Calander, A., Starckx, S., Opdenakker, G., Bergin, P. J., Quiding‐Järbrink, M., & Tarkowski, A. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.01.001 · Cited by 34
Blüml, S., Sahin, E., Saferding, V., Gonçalves‐Alves, E., Hainzl, E., Niederreiter, B., Hladik, A., Lohmeyer, T., Brunner, J. S., Bonelli, M. M., et al. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0742-y · Cited by 33
Self-citationNovel targets in bone and cartilage
Beyer, C., & Schett, G. A. (2010) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2010.03.001 · Cited by 35
Self-citationNarducci, P., Bareggi, R., & Nicolin, V. (2009) · Acta Histochemica · doi:10.1016/j.acthis.2009.10.003 · Cited by 38
Lee, C. H., Bae, S. J., & Kim, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-12349-9 · Cited by 32
Carpenter, L., Norton, S., Nikiphorou, E., Jayakumar, K., McWilliams, D. F., Rennie, K. L., Dixey, J., Kiely, P., Walsh, D. A., Young, A., et al. (2017) · Arthritis Care & Research · doi:10.1002/acr.23217 · Cited by 32
Dai, S.-P., Hsieh, W.-S., Chen, C.-H., Lu, Y.-H., Huang, H., Chang, D.-M., Huang, S., & Sun, W. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01851-z · Cited by 32
IKKβ as a target for treatment of inflammation induced bone loss
Ruocco, M. G., & Karin, M. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.042721 · Cited by 35
Emerging anti-osteoclast therapy for rheumatoid arthritis
Tanaka, S. (2018) · Journal of Orthopaedic Science · doi:10.1016/j.jos.2018.06.001 · Cited by 32
Hirayama, T., Dai, S., Abbas, S., Yamanaka, Y., & Abu‐Amer, Y. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21286 · Cited by 37
Regulatory T-cell dynamics with abatacept treatment in rheumatoid arthritis
Langdon, K., & Haleagrahara, N. (2018) · International Reviews of Immunology · doi:10.1080/08830185.2018.1465943 · Cited by 30
Trigger-responsive engineered-nanocarriers and image-guided theranostics for rheumatoid arthritis
Ahamad, N., Prabhakar, A., Mehta, S., Singh, E., Bhatia, E., Sharma, S., & Banerjee, R. (2020) · Nanoscale · doi:10.1039/d0nr01648a · Cited by 30
Herman, S., Fischer, A., Présumey, J., Hoffmann, M. H., Koenders, M. I., Escriou, V., Apparailly, F., & Steiner, G. E. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39223 · Cited by 29
Self-citationB-Cell Infiltrates Induce Endosteal Bone Formation in Inflammatory Arthritis
Hayer, S., Polzer, K., Brandl, A., Zwerina, J., Kireva, T., Smolen, J. S., & Schett, G. A. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080508 · Cited by 29
Self-citationKitaura, H., Tatamiya, M., Nagata, N., Fujimura, Y., Eguchi, T., Yoshida, N., & Nakayama, K. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.06.005 · Cited by 34
The burden of rheumatoid arthritis and access to treatment: a medical overview
Smolen, J. S., & Aletaha, D. (2007) · The European Journal of Health Economics · doi:10.1007/s10198-007-0087-9 · Cited by 30
Self-citationKwak, H. B., Jin, H., Ha, H., Kang, M., Lee, S. B., Kim, H., & Lee, Z. H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.085 · Cited by 33
Osteoimmunology and Bone Homeostasis: Relevance to Spondyloarthritis
Goldring, S. R. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-013-0342-2 · Cited by 57
Győri, D., Csete, D., Benkő, S., Kulkarni, S., Mandl, P., Dobó‐Nagy, C., Vanhaesebroeck, B., Stephens, L., Hawkins, P. T., & Mócsai, A. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38660 · Cited by 29
Jiang, Y., Wen, J., Zhao, X., Gao, Y., Ma, X., Song, S., Jin, Y., Shao, T., Yu, J., & Wen, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010279 · Cited by 31
Tanshinone IIA inhibits osteoclastogenesis in rheumatoid arthritis via LDHC-regulated ROS generation
Peng, Q., Wang, J., Han, M., Zhao, M., Li, K., Lu, T., Guo, Q., & Jiang, Q. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00765-1 · Cited by 29
Rheumatoid arthritis molecular targets and their importance to flavonoid‐based therapy
Rufino, A. T., Freitas, M., Proença, C., de Oliveira, J. M. P. F., Fernandes, E. G. R., & Ribeiro, D. (2023) · Medicinal Research Reviews · doi:10.1002/med.21990 · Cited by 30
Structural Joint Damage in Gout
Chhana, A., & Dalbeth, N. (2014) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2014.01.006 · Cited by 32
Inhibition of rheumatoid arthritis by blocking connective tissue growth factor
Nozawa, K., Fujishiro, M., Takasaki, Y., & Sekigawa, I. (2014) · World Journal of Orthopedics · doi:10.5312/wjo.v5.i5.653 · Cited by 28
Anti-c-Fms antibody inhibits lipopolysaccharide-induced osteoclastogenesis in vivo
Kimura, K., Kitaura, H., Fujii, T., Hakami, Z. W., & Takano‐Yamamoto, T. (2011) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2011.00888.x · Cited by 31
Kubota, T., Hoshino, M., Aoki, K., Ohya, K., Komano, Y., Nanki, T., Miyasaka, N., & Umezawa, K. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2298 · Cited by 32
Park, S. Y., Lee, S. W., Lee, W. S., Rhim, B. Y., Lee, S. J., Kwon, S., Hong, K. W., & Kim, C. D. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.08.017 · Cited by 28
The Craniovertebral Junction in Rheumatoid Arthritis: State of the Art
Ferrante, A., Ciccia, F., Giammalva, G. R., Iacopino, D. G., Visocchi, M., Macaluso, F., & Maugeri, R. (2019) · Acta neurochirurgica. Supplementum · doi:10.1007/978-3-319-62515-7_12 · Cited by 27
Mukai, T., Gallant, R., Ishida, S., Yoshitaka, T., Kittaka, M., Nishida, K., Fox, D. A., Morita, Y., & Ueki, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105518 · Cited by 31
Huang, J., Xie, B., Li, Q., Xie, X., Zhu, S., Wang, M., Peng, W., & Gu, J. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.10.030 · Cited by 29
Osteoporosis in psoriatic arthritis: an assessment of densitometry and fragility fractures
Riesco, M., Manzano, F., Font, P., García, A., & Solé, J. M. N. (2013) · Clinical Rheumatology · doi:10.1007/s10067-013-2322-3 · Cited by 27
Osteopontin Has a Crucial Role in Osteoclast‐Like Multinucleated Giant Cell Formation
Oh, Y., Oh, I., Morimoto, J. O., Uede, T., & Morimoto, A. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24695 · Cited by 27
Type 17 T-helper cells might be a promising therapeutic target for osteoporosis
Yuan, F., Li, X., Lü, W., Zhao, Y., Li, C.-W., Li, J.-P., Sun, J., & Xu, R. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-0797-z · Cited by 26
Terashima, A., Ono, K., Omata, Y., Tanaka, S., & Saito, T. (2024) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-024-01520-8 · Cited by 29
Inoue, H., Arai, Y., Kishida, T., Shin‐Ya, M., Terauchi, R., Nakagawa, S., Saito, M., Tsuchida, S., Inoue, A., Shirai, T., et al. (2013) · Ultrasonics · doi:10.1016/j.ultras.2013.10.021 · Cited by 27
Fu, L., Pan, F., & Jiao, Y. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.11.009 · Cited by 25
Jing, W., Sun, W., Zhang, N., Zhao, C., & Yan, X. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172663 · Cited by 27
An anti‐c‐Fms antibody inhibits osteoclastogenesis in a mouse periodontitis model
Kimura, K., Kitaura, H., Fujii, T., Ishida, M., Hakami, Z., & Takano‐Yamamoto, T. (2013) · Oral Diseases · doi:10.1111/odi.12117 · Cited by 29
Modulation of Osteoclastogenesis Induced by Nucleoside Reverse Transcriptase Inhibitors
Pan, G., Kilby, M., & McDonald, J. M. (2006) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.22.1131 · Cited by 27
Effect of TNF-α on osteocyte RANKL expression during orthodontic tooth movement
Marahleh, A., Kitaura, H., Ohori, F., Noguchi, T., Nara, Y., Pramusita, A., Kinjo, R., Ma, J., Kanou, K., & Mizoguchi, I. (2021) · Journal of Dental Sciences · doi:10.1016/j.jds.2021.03.006 · Cited by 29
A Review on Rheumatoid Arthritis Interventions and Current Developments
Khanna, N., Kumar, A., & Pawar, S. V. (2020) · Current Drug Targets · doi:10.2174/1389450121999201125200558 · Cited by 26
Komagamine, M., Komatsu, N., Ling, R., Okamoto, K., Tianshu, S., Matsuda, K., Takeuchi, T., Kaneko, Y., & Takayanagi, H. (2023) · Inflammation and Regeneration · doi:10.1186/s41232-023-00293-3 · Cited by 26
Jin, H., Kee, S., Cho, Y., Kang, J., Kim, M., Jung, H., Park, K., Kim, T., Lee, S., Choi, H. J., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39244 · Cited by 24
TNFα promotes proliferation of human synovial MSCs while maintaining chondrogenic potential
Shioda, M., Muneta, T., Tsuji, K., Mizuno, M., Komori, K., Koga, H., & Sekiya, I. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177771 · Cited by 26
Kaur, I., Behl, T., BUNGAU, S. G., Zengin, G., Kumar, A., El-Esawi, M. A., Khullar, G., Venkatachalam, T., & Arora, S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118109 · Cited by 27
RetractedHistone deacetylase inhibitors as suppressors of bone destruction in inflammatory diseases
Cantley, M. D., Bartold, P. M., Fairlie, D. P., Rainsford, K. D., & Haynes, D. R. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01421.x · Cited by 24
Kitaura, H., Fujimura, Y., Yoshimatsu, M., Eguchi, T., Kohara, H., Jang, I., Morita, Y., & Yoshida, N. (2009) · The Angle Orthodontist · doi:10.2319/080708-412.1 · Cited by 24
Metadata
- Authors
- Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F., & Schett, G.
- Affiliations
- University of Vienna (AT)
- Vienna Biocenter (AT)
- Research Institute of Molecular Pathology (AT)
- Alexander Fleming Biomedical Sciences Research Center (GR)
- Corresponding author
- Schett, Georg
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2002-11-15
- Volume
- 110
- Issue
- 10
- Pages
- 1419-1427
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4248559208
- Cited by
- 474
- References
- 40
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 11 · 2023: 11 · 2022: 11 · 2021: 12 · 2020: 24 · 2019: 16 · 2018: 16 · 2017: 15 · 2016: 16 · 2015: 24 · 2014: 22 · 2013: 25 · 2012: 29
- FWCI
- 11.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Funders
- Austrian Science Fund
- Oesterreichische Nationalbank
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Keywords
- osteoclasts, TNF-α, rheumatoid arthritis, joint destruction, bone erosion, osteopetrotic mice, transgenic mice, synovitis, cartilage damage, matrix metalloproteinases, MMP-13, MMP-3, MMP-9, chondrocytes, osteoclast inhibition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.